Atellica CH Enzymatic Creatinine_3 (ECre3)

Enzymatic Method, Creatinine

Siemens Healthcare Diagnostics Inc.

The following data is part of a premarket notification filed by Siemens Healthcare Diagnostics Inc. with the FDA for Atellica Ch Enzymatic Creatinine_3 (ecre3).

Pre-market Notification Details

Device IDK212223
510k NumberK212223
Device Name:Atellica CH Enzymatic Creatinine_3 (ECre3)
ClassificationEnzymatic Method, Creatinine
Applicant Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue Tarrytown,  NY  10591
ContactIan Thompson
CorrespondentIan Thompson
Siemens Healthcare Diagnostics Inc. 511 Benedict Avenue Tarrytown,  NY  10591
Product CodeJFY  
CFR Regulation Number862.1225 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2021-07-16
Decision Date2021-11-24

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414301587 K212223 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.